Fitzgerald Pharmacology Midterm Practice
Questions with Answers Latest Update
2025/2026 Brand New!!!
Which of the following medications should be used with caution in a person with
suspected or known sulfa allergy?
A. metformin
B. glyburide
C. rosiglitazone
D. NPH insulin
B
The mechanism of action of metformin (Glucophage) is as:
A. an insulin production enhancer
B. a product virtually identical in action to sulfonylureas
C. a drug that increases insulin action in the peripheral tissues and reduces
hepatic glucose production
D. a facilitator of renal glucose excretion
C
,Generally, testing for T2DM in asymptomatic undiagnosed individuals older than
45 yo should be conducted every:
A. year
B. 3 years
C. 5 years
D. 10 years
B
You are seeing 17 yo Cynthia. As part of the visit, you consider her risk factors for
T2DM would likely include all of the following except:
A. obesity
B. Native American ancestry
C. family history of T1DM
D. personal history of polycystic ovary syndrome
C
Criteria for the diagnosis of T2DM include:
A. classic symptoms regardless of FPG
B. plasma glucose of 126 as a random measurement
C. a 2 hour glucose measurement of 156 after a 75g anhydrous glucose load
D. plasma glucose of 126 after an 8 hour fast on more than one occasion
D
,The mechanism of action of pioglitazone is as:
A. an insulin production enhancer
B. a reduce or pancreatic glucose output
C. an insulin sensitizer
D. a facilitator of renal glucose excretion
C
Which of the following should be the goal measurement in treating a person with
DM and HTN?
A. BP less than 140/90
B. HA1C of 7 or greater
C. TG 200-300
D. HDL 35-40
A
In caring for a patient with DM, microalbuminuria measurement should be
obtained:
A. annually if urine protein is present
B. periodically in relationship to glycemia control
C. yearly
D. with each office visit related to DM
C
, The mechanism of action of sulfonylureas is as:
A. an antagonist of insulin receptor site activity
B. a product that enhances insulin release
C. a facilitator of renal glucose excretion
D. an agent that can reduce hepatic glucose production
B
When caring for a patient with DM, HTN, and persistent proteinuria, the NP
prioritizes the choice of antiHTN and prescribes:
A. furosemide
B. methyldopa
C. fosinopril
D. nifedipnie
C
Clinical presentation of T1DM usually includes all of the following except:
A. report of recent unintended weight gain
B. ketosis
C. thirst
D. polyphagia
A
Questions with Answers Latest Update
2025/2026 Brand New!!!
Which of the following medications should be used with caution in a person with
suspected or known sulfa allergy?
A. metformin
B. glyburide
C. rosiglitazone
D. NPH insulin
B
The mechanism of action of metformin (Glucophage) is as:
A. an insulin production enhancer
B. a product virtually identical in action to sulfonylureas
C. a drug that increases insulin action in the peripheral tissues and reduces
hepatic glucose production
D. a facilitator of renal glucose excretion
C
,Generally, testing for T2DM in asymptomatic undiagnosed individuals older than
45 yo should be conducted every:
A. year
B. 3 years
C. 5 years
D. 10 years
B
You are seeing 17 yo Cynthia. As part of the visit, you consider her risk factors for
T2DM would likely include all of the following except:
A. obesity
B. Native American ancestry
C. family history of T1DM
D. personal history of polycystic ovary syndrome
C
Criteria for the diagnosis of T2DM include:
A. classic symptoms regardless of FPG
B. plasma glucose of 126 as a random measurement
C. a 2 hour glucose measurement of 156 after a 75g anhydrous glucose load
D. plasma glucose of 126 after an 8 hour fast on more than one occasion
D
,The mechanism of action of pioglitazone is as:
A. an insulin production enhancer
B. a reduce or pancreatic glucose output
C. an insulin sensitizer
D. a facilitator of renal glucose excretion
C
Which of the following should be the goal measurement in treating a person with
DM and HTN?
A. BP less than 140/90
B. HA1C of 7 or greater
C. TG 200-300
D. HDL 35-40
A
In caring for a patient with DM, microalbuminuria measurement should be
obtained:
A. annually if urine protein is present
B. periodically in relationship to glycemia control
C. yearly
D. with each office visit related to DM
C
, The mechanism of action of sulfonylureas is as:
A. an antagonist of insulin receptor site activity
B. a product that enhances insulin release
C. a facilitator of renal glucose excretion
D. an agent that can reduce hepatic glucose production
B
When caring for a patient with DM, HTN, and persistent proteinuria, the NP
prioritizes the choice of antiHTN and prescribes:
A. furosemide
B. methyldopa
C. fosinopril
D. nifedipnie
C
Clinical presentation of T1DM usually includes all of the following except:
A. report of recent unintended weight gain
B. ketosis
C. thirst
D. polyphagia
A
